Fundraising Fox

Johan Lund

Investor

Venture Partner at Sciety

Greater Stockholm Metropolitan Area

About

Johan Lund is a physician and former professor with a PhD from Karolinska Institutet and over 25 years of experience in drug development across academia and industry. He has held senior research leadership roles at AstraZeneca, Pfizer, and Celgene, focusing on inflammation, immunology, and CNS, including serving as Chief Scientific Officer for Inflammation & Immunology at Pfizer. As Venture Partner at Sciety, he supports the evaluation of investment opportunities and helps portfolio companies translate scientific research to market.

Contact· self-published, not guessed

Invests in

BiotechHealthtech

Experience

  1. Mesenkia Therapeutics ABCo-founder and Chairman of the Boardcurrent2025 — presentUppsala, Uppsala County, Sweden
  2. Mesenkia Therapeutics ABInterim Chief Executive Officer and co-founder2023 — 2025Uppsala, Uppsala County, Sweden
  3. AQILION ABChief Scientific Officercurrent2021 — present
  4. AQILION ABChairman Of The Board2018 — 2022Helsingborg, Sweden
  5. NEOGAP Therapeutics ABChairman of the Board of Directorscurrent2019 — present
  6. Pelago Bioscience ABMember Board Of Directorscurrent2021 — present
  7. ScietyVenture Partnercurrent2025 — present
  8. PharmNovoChairman of the Boardcurrent2025 — present
  9. MBS PharmaFoundercurrent2018 — presentBjärred, Sweden
  10. NeuVentis Therapeutics ABCEO and Co-Foundercurrent2018 — presentStockholm, Sweden
  11. Olink ProteomicsBoard member2017 — 2024Uppsala, Sweden
  12. LIDDSMember Board Of Directors2022 — 2024
  13. Genagon TherapeuticsMember Board Of Directors2019 — 2024
  14. Celgene PharmaVice President2016 — 2017Cambridge, MA
  15. EIT Health Scandinavian CLCBoard Member2015 — 2016Greater Stockholm Metropolitan Area
  16. Karolinska InstitutetSenior Specialist & Program Lead EIT Health2015 — 2016Greater Stockholm Metropolitan Area
  17. J. Lund & Associates, LLCManaging Partner2015 — 2016Brookline, MA
  18. PfizerSenior Vice President & Chief Scientific Officer, Immunoscience Research Unit2012 — 2015Cambridge, MA, USA
  19. AstraZenecaVice President2008 — 2012
  20. AstraZenecaVice President2007 — 2008
  21. AstraZenecaVice president2005 — 2007
  22. AstraZenecaDirector2003 — 2005
  23. AstraZenecaDirector2000 — 2003
  24. AstraZenecaDirector1999 — 2000
  25. University of BergenProfessor1996 — 1999
  26. Karolinska InstitutetAssociate Professor1990 — 1996
  27. UT Southwestern Medical Center at DallasResearch Fellow1987 — 1989

Skills & more

Drug Discovery99Clinical Development41Lifesciences26Drug Development81Neuroscience26Pharmacology35Pharmaceutical Industry54Biomarkers33Molecular Biology99Immunology99Science25In Vivo5
+12 moreMedical AffairsR&DInflammationBiotechnologyBiochemistryTranslational MedicineCROIn VitroINDMedicinal ChemistryClinical TrialsToxicology

From Johan's professional profile.

Investments

Board seats

MesenkiaNeogap TherapeuticsOlinkPharmNovo

Per the firm's website.

Colleagues at Sciety

Frequently asked questions

Who is Johan Lund?
Johan Lund is a physician and former professor with a PhD from Karolinska Institutet and over 25 years of experience in drug development across academia and industry. He has held senior research leadership roles at AstraZeneca, Pfizer, and Celgene, focusing on inflammation, immunology, and CNS, including serving as Chief Scientific Officer for Inflammation & Immunology at Pfizer. As Venture Partner at Sciety, he supports the evaluation of investment opportunities and helps portfolio companies translate scientific research to market.
Where does Johan Lund work?
Johan Lund is Venture Partner at Sciety.
What does Johan Lund invest in?
Johan Lund invests in Biotech, Healthtech.
What boards does Johan Lund sit on?
Johan Lund holds tracked board seats at Mesenkia, Neogap Therapeutics, Olink, PharmNovo.
Where did Johan Lund go to school?
Johan Lund studied at Karolinska Institutet (MD/PhD).

Same school

Shared employers